A prior study demonstrated a synthetic lethal relationship between VHL inactivation and loss of CDK4/6 activity.107 The combination of CDK4/6 inhibitor and belzutifan was shown to promote synergistic suppression of tumor growth ex vivo. Here, CDK4 is linked to neoplasm.